AM 003
Alternative Names: AM-003Latest Information Update: 13 Jul 2024
At a glance
- Originator Aummune
- Class Antineoplastics; Nucleotide aptamers
- Mechanism of Action Immunologic cytotoxicity; T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Solid tumours